SAN DIEGO--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed ...
In 2021, the market was valued at USD 912.5 million, and it is projected to reach USD 1,841.2 million by 2028, growing at a CAGR of 11.0% during 2022-2028. Key factors driving this growth include: The ...
Fapon at Medlab Middle East 2025: Advancing Local Diagnostic Industry through One-stop IVD Solutions
DUBAI, UAE, Feb. 3, 2025 /PRNewswire/ -- Fapon, a global leading life sciences company, is showcasing its comprehensive one-stop IVD solutions and sharing the latest industry insights with global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback